Masataka Hikota

763 total citations
16 papers, 641 citations indexed

About

Masataka Hikota is a scholar working on Organic Chemistry, Molecular Biology and Biochemistry. According to data from OpenAlex, Masataka Hikota has authored 16 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Organic Chemistry, 7 papers in Molecular Biology and 5 papers in Biochemistry. Recurrent topics in Masataka Hikota's work include Synthetic Organic Chemistry Methods (9 papers), Carbohydrate Chemistry and Synthesis (4 papers) and Traditional and Medicinal Uses of Annonaceae (4 papers). Masataka Hikota is often cited by papers focused on Synthetic Organic Chemistry Methods (9 papers), Carbohydrate Chemistry and Synthesis (4 papers) and Traditional and Medicinal Uses of Annonaceae (4 papers). Masataka Hikota collaborates with scholars based in Japan and United States. Masataka Hikota's co-authors include Osamu Yonemitsu, Kiyoshi Horita, Hitoshi Tone, Dale L. Boger, M. Ishida, Jiyong Hong, Bryan M. Lewis, Takao Nishi, Yuji Oikawa and Kotomi Fujishige and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Organic Chemistry and Tetrahedron.

In The Last Decade

Masataka Hikota

16 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masataka Hikota Japan 11 550 180 139 139 44 16 641
S. GILMAN 6 591 1.1× 190 1.1× 90 0.6× 116 0.8× 37 0.8× 6 716
Kunio Ogasawara Japan 18 885 1.6× 268 1.5× 96 0.7× 88 0.6× 67 1.5× 60 1.0k
Machiko Ono Japan 16 529 1.0× 206 1.1× 88 0.6× 59 0.4× 33 0.8× 68 649
Cameron J. Cowden United Kingdom 19 743 1.4× 227 1.3× 112 0.8× 77 0.6× 77 1.8× 31 837
Jean‐Louis Gras France 14 548 1.0× 224 1.2× 56 0.4× 53 0.4× 44 1.0× 40 669
R. J. Arhart United States 8 423 0.8× 113 0.6× 83 0.6× 77 0.6× 32 0.7× 12 514
William H. Moser United States 17 891 1.6× 157 0.9× 91 0.7× 183 1.3× 71 1.6× 22 947
Masahiro Miyazawa Japan 18 749 1.4× 181 1.0× 93 0.7× 96 0.7× 113 2.6× 58 815
M. HOSHINO Japan 12 533 1.0× 224 1.2× 68 0.5× 56 0.4× 49 1.1× 21 648
A. ZAMOJSKI Poland 11 518 0.9× 210 1.2× 118 0.8× 70 0.5× 33 0.8× 29 637

Countries citing papers authored by Masataka Hikota

Since Specialization
Citations

This map shows the geographic impact of Masataka Hikota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masataka Hikota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masataka Hikota more than expected).

Fields of papers citing papers by Masataka Hikota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masataka Hikota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masataka Hikota. The network helps show where Masataka Hikota may publish in the future.

Co-authorship network of co-authors of Masataka Hikota

This figure shows the co-authorship network connecting the top 25 collaborators of Masataka Hikota. A scholar is included among the top collaborators of Masataka Hikota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masataka Hikota. Masataka Hikota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sakamoto, Toshiaki, Yuichi Koga, Masataka Hikota, et al.. (2015). 8-(3-Chloro-4-methoxybenzyl)-8H-pyrido[2,3-d]pyrimidin-7-one derivatives as potent and selective phosphodiesterase 5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(7). 1431–1435. 12 indexed citations
2.
Sakamoto, Toshiaki, Yuichi Koga, Masataka Hikota, et al.. (2014). The discovery of avanafil for the treatment of erectile dysfunction: A novel pyrimidine-5-carboxamide derivative as a potent and highly selective phosphodiesterase 5 inhibitor. Bioorganic & Medicinal Chemistry Letters. 24(23). 5460–5465. 25 indexed citations
3.
Sakamoto, Toshiaki, Yuichi Koga, Masataka Hikota, et al.. (2014). Design and synthesis of novel 5-(3,4,5-trimethoxybenzoyl)-4-aminopyrimidine derivatives as potent and selective phosphodiesterase 5 inhibitors: Scaffold hopping using a pseudo-ring by intramolecular hydrogen bond formation. Bioorganic & Medicinal Chemistry Letters. 24(22). 5175–5180. 21 indexed citations
4.
Boger, Dale L., Jiyong Hong, Masataka Hikota, & M. Ishida. (1999). Total Synthesis of Phomazarin. Journal of the American Chemical Society. 121(11). 2471–2477. 92 indexed citations
5.
Boger, Dale L., Masataka Hikota, & Bryan M. Lewis. (1997). Determination of the Relative and Absolute Stereochemistry of Fostriecin (CI-920). The Journal of Organic Chemistry. 62(6). 1748–1753. 50 indexed citations
8.
Yonemitsu, Osamu, Noriyuki Nakajima, & Masataka Hikota. (1990). Synthesis of macrolides.. Journal of Synthetic Organic Chemistry Japan. 48(2). 102–118. 2 indexed citations
9.
Hikota, Masataka, Hitoshi Tone, Kiyoshi Horita, & Osamu Yonemitsu. (1990). Stereoselective synthesis of erythronolide a by extremely efficient lactonization based on conformational adjustment and high activation of seco-acid1. Tetrahedron. 46(13-14). 4613–4628. 70 indexed citations
10.
Hikota, Masataka, et al.. (1990). Synthesis of erythronolide a via a very efficient macrolactonization under usual acylation conditions with the Yamaguchi reagent. Tetrahedron Letters. 31(44). 6367–6370. 144 indexed citations
11.
Hikota, Masataka, Hitoshi Tone, Kiyoshi Horita, & Osamu Yonemitsu. (1990). Chiral synthesis of polyketide-derived natural products. 27. Stereoselective synthesis of erythronolide A via an extremely efficient macrolactonization by the modified Yamaguchi method. The Journal of Organic Chemistry. 55(1). 7–9. 116 indexed citations
12.
Tone, Hitoshi, Masataka Hikota, Tatsuo Hamada, et al.. (1989). Alternative syntheses of the C9-C15 and C1-C5 segments of erythronolide A via regio- and stereo-selective reductive ring opening of 2,3-epoxy alcohols.. Chemical and Pharmaceutical Bulletin. 37(5). 1155–1159. 2 indexed citations
13.
Hamada, Tatsuo, Hiroki Sato, Masataka Hikota, & Osamu Yonemitsu. (1989). Diels-alder reaction of chiral dienes. Remarkable effect of dienophile polarity upon diastereo face selectivity. Tetrahedron Letters. 30(46). 6405–6408. 17 indexed citations
14.
Tone, Hitoshi, Takao Nishi, Yuji Oikawa, Masataka Hikota, & Osamu Yonemitsu. (1989). A stereoselective total synthesis of (9S)-9-dihydroerythronolide A via coupling between the right-half (C1-C6) aldehyde and the left-half (C7-C15) sulfoxide.. Chemical and Pharmaceutical Bulletin. 37(5). 1167–1172. 7 indexed citations
15.
Tone, Hitoshi, Takao Nishi, Yuji Oikawa, Masataka Hikota, & Osamu Yonemitsu. (1989). Synthetic study of (9S)-9-dihydroerythronolide A via Wittig-Horner coupling of C1-C6 and C7-C15 segments.. Chemical and Pharmaceutical Bulletin. 37(5). 1160–1166. 4 indexed citations
16.
Tone, Hitoshi, Takao Nishi, Yuji Oikawa, Masataka Hikota, & Osamu Yonemitsu. (1987). A stereoselective total synthesis of (9S)-9-dihydroerythronolide A from D-glucose. Tetrahedron Letters. 28(39). 4569–4572. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026